Evidence map›Paper›PMID 27657136›Full record

ArticleGenes2016

Regulation of BLM Nucleolar Localization.

Larissa Tangeman, Michael A McIlhatton, Patrick Grierson, Joanna Groden, Samir Acharya

Open access · goldAbstract read
In one paragraph

Article in Genes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Keeping ribosomal DNA intact: a repeating challenge.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2019
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Larissa TangemanDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA. larissa.tangeman@osumc.edu.
Michael A McIlhattonDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA. michael.mcilhatton@osumc.edu.
Patrick GriersonDivisions of Hematology and Medical Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. grierson@wustl.edu.
Joanna GrodenDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA. joanna.groden@osumc.edu.
Samir AcharyaDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA. samir.acharya@osumc.edu.
The Ohio State University · USWashington University in St. Louis · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
The Ohio State University Center for Clinical and Translational Science (UL1)UL1TR000090 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$7.9M
Functions of the BLM Helicase in Telomere MaintenanceR01CA117898 · NCI · OHIO STATE UNIVERSITY · PI GRODEN, JOANNA LOUISE · 2008 to 2012
$1.5M
The Ohio State University Center for Clinical and Translational Science (KL2)KL2TR000112 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$855k
The Ohio State University Center for Clinical and Translational Science (TL1)TL1TR000091 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$384k
NCATS NIH HHS KL2 TR000112NCATS NIH HHS TL1 TR000091NCATS NIH HHS UL1 TR000090NCATS NIH HHS UL1 TR001070NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA117898
6 · The paper itself

Abstract

Defects in coordinated ribosomal RNA (rRNA) transcription in the nucleolus cause cellular and organismal growth deficiencies. Bloom's syndrome, an autosomal recessive human disorder caused by mutated recQ-like helicase BLM, presents with growth defects suggestive of underlying defects in rRNA transcription. Our previous studies showed that BLM facilitates rRNA transcription and interacts with RNA polymerase I and topoisomerase I (TOP1) in the nucleolus. The mechanisms regulating localization of BLM to the nucleolus are unknown. In this study, we identify the TOP1-interaction region of BLM by co-immunoprecipitation of in vitro transcribed and translated BLM segments and show that this region includes the highly conserved nuclear localization sequence (NLS) of BLM. Biochemical and nucleolar co-localization studies using site-specific mutants show that two serines within the NLS (S1342 and S1345) are critical for nucleolar localization of BLM but do not affect the functional interaction of BLM with TOP1. Mutagenesis of both serines to aspartic acid (phospho-mimetic), but not alanine (phospho-dead), results in approximately 80% reduction in nucleolar localization of BLM while retaining the biochemical functions and nuclear localization of BLM. Our studies suggest a role for this region in regulating nucleolar localization of BLM via modification of the two serines within the NLS.

Indexed as

BLMBloom’s syndromegrowth defectsnucleolar localizationrRNA transcriptiontopoisomerase I

Identifiers

PMID27657136
PMCPMC5042399
OpenAlexW2522453658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.